Human alveolar and tracheobronchial and GUT tissues for rapid characterization of sars-COV-2 variants
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00176
- Awardee
-
Mattek Corporation UEI Q1V1JV6GJW77
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,126
Award facts
- Opportunity
-
- Human Alveolar and Tracheobronchial and Gut Tissues for Rapid Characterization of SARS-CoV-2 Variants Special Notice · Posted Feb 16, 2022
- Contract value 100% obligated
- $225,126.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Ashland, MA 01721, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $225,126 |
About this award
This is a sole-source contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Mattek Corp, a for-profit manufacturer of human tissue models. The $225,126 Firm Fixed Price contract is for the delivery of human alveolar, tracheobronchial, and gut tissue samples to support NCATS' efforts to rapidly characterize SARS-CoV-2 variants and test antiviral therapies. The contract does not have a set-aside designation, as NCATS determined Mattek was the only vendor capable of providing the required tissue models. Mattek has previously supported federal biomedical research through prime and subcontract work with NIH, CDC, EPA, and the Navy, providing specialized human and animal tissue models for disease, toxicity, and wound healing studies.
Quick answers
Who was awarded contract 75N95022P00176?
75N95022P00176 was awarded to Mattek Corporation by National Institute on Drug Abuse (National Institutes of Health) on March 22, 2022.
How much is contract 75N95022P00176 worth?
The government has obligated $225,126 on 75N95022P00176.
Which agency awarded contract 75N95022P00176?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00176, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00176 competed?
The extent of competition for 75N95022P00176 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award